Developer docs
API playgroundTry for free, no card

Search company profiles

ODS Medical

Full company profile

uuid0009u7b

Namestring
ODS Medical
Legal namestring
Key-Systems GmbH
Websiteurl
odsmed.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

ODS Medical is a Montréal-based medical device company founded in 2015 that is developing a Raman spectroscopy system intended for medical applications, with the company describing the platform as exclusive to them. Raman spectroscopy uses inelastic light scattering to characterize molecular composition of tissue, and in a surgical/oncology context it is typically applied toward intraoperative margin assessment or non-invasive diagnostic guidance. The company was founded by Kirk Urmey, Kevin Petrecca (who serves as CMO), and Eric Marple, with Christopher Kent serving as President and CEO.

The business has historically targeted the medtech commercialization pathway, drawing backing from a sequence of Canadian and international supporters — Anges Quebec (2016), Creative Destruction Lab (2017), MedTech Innovator (2018), and a 2020 round led by Zoic Capital with participation from MEDTEQ+ and SGInnovate. These investors and program affiliations suggest a strategy of leveraging Quebec-based angel capital, accelerator validation, and pan-North-American and Singapore ecosystem access to advance the technology toward regulatory clearance and commercial launch.

As of the data captured here, ODS Medical shows material operational distress signals: its corporate website (odsmed.com) has expired and displays only a registrar's Expired Registration Recovery Policy notice, the operating status is flagged as "closed," and there is no record of products in market, customer relationships, pricing, distribution, or revenue. The structured contact information resolves to Key-Systems GmbH, a German domain registrar, rather than to the company itself. No patents, regulatory approvals, certifications, or post-2020 strategic activity are documented, indicating the company is either dormant, in turnaround, or no longer an active operating entity.

Short descriptiontext

ODS Medical is a Montréal-based medical device company developing an exclusive Raman spectroscopy system for medical applications. Founded in 2015, the firm has historically targeted medtech commercialization but shows operational distress signals including an expired corporate domain and no documented commercial activity.

Operating statusenum
Closed
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontreal, Canada
HQ citystring
Montreal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical devices, Raman spectroscopy, diagnostic imaging, surgical guidance systems, optical spectroscopy
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Laboratory Analytical Instruments3826
Product category
Medical Diagnostic Devices
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ODS Medical is a medical device company developing and seeking to commercialize an exclusive Raman spectroscopy system. The system is positioned for diagnostic and intraoperative clinical applications, enabling optical tissue analysis for medical and surgical use cases. The company's primary commercial objective is to bring this proprietary Raman spectroscopy platform to healthcare markets.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available. The website (odsmed.com) displays only an expired domain registration notice with no product, service, or technology offerings.

Product and service1 record
1Raman Spectroscopy System
CategoryMedical Diagnostic Devices
Description

An exclusive Raman spectroscopy-based medical device intended for clinical and intraoperative diagnostic applications, enabling optical tissue analysis for healthcare providers and surgical teams.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Commercializes the Cellvizio probe-based optical biopsy platform for in-vivo tissue characterization during endoscopy and surgery. Directly comparable to ODS Medical as an optical/spectroscopy-based real-time tissue diagnostic medical device.

TypeDirect peer
Description

Canadian company developing Raman spectroscopy-based systems for skin cancer detection. Closely comparable in modality (Raman), clinical use case (cancer detection), and geography (Canada).

TypeDirect peer
Description

Canadian AI-enabled OCT imaging company focused on real-time cancer margin assessment in the operating room. Comparable as a Canadian medtech commercializing optical tissue-analysis devices for surgical oncology.

TypeEmerging player
Description

Develops optical coherence tomography (OCT)-based cardiac imaging catheters. Comparable as a developer of optical diagnostic devices for clinical decision-making, though focused on cardiology rather than oncology/tissue spectroscopy.

TypeEmerging player
Description

Uses spatial frequency domain imaging plus AI for tissue health assessment (e.g., diabetic foot, burns). Adjacent to ODS through the combination of optical physics and AI/ML for tissue characterization in clinical settings.

TypeEmerging player
Description

Applies multi-spectral imaging and AI to wound care and burn assessment. Comparable through the use of optical spectroscopy/imaging with machine learning for clinical diagnostics.

TypeBroad incumbent
Description

Global manufacturer of Raman spectroscopy systems widely used in research and increasingly in medical/clinical research. Comparable as an established supplier of Raman spectroscopy instrumentation, though not exclusively medical-device focused.

TypeBroad incumbent
Description

Major manufacturer of Raman spectrometers and other analytical instruments with medical and life-science applications. Comparable as a broad incumbent in Raman spectroscopy hardware serving clinical and biomedical markets.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ODS Medical

Medical Diagnostic Devicesodsmed.com

ODS Medical is a Montréal-based medical device company developing an exclusive Raman spectroscopy system for medical applications. Founded in 2015, the firm has historically targeted medtech commercialization but shows operational distress signals including an expired corporate domain and no documented commercial activity.

What ODS Medical does

ODS Medical is a Montréal-based medical device company founded in 2015 that is developing a Raman spectroscopy system intended for medical applications, with the company describing the platform as exclusive to them. Raman spectroscopy uses inelastic light scattering to characterize molecular composition of tissue, and in a surgical/oncology context it is typically applied toward intraoperative margin assessment or non-invasive diagnostic guidance. The company was founded by Kirk Urmey, Kevin Petrecca (who serves as CMO), and Eric Marple, with Christopher Kent serving as President and CEO.

The business has historically targeted the medtech commercialization pathway, drawing backing from a sequence of Canadian and international supporters — Anges Quebec (2016), Creative Destruction Lab (2017), MedTech Innovator (2018), and a 2020 round led by Zoic Capital with participation from MEDTEQ+ and SGInnovate. These investors and program affiliations suggest a strategy of leveraging Quebec-based angel capital, accelerator validation, and pan-North-American and Singapore ecosystem access to advance the technology toward regulatory clearance and commercial launch.

As of the data captured here, ODS Medical shows material operational distress signals: its corporate website (odsmed.com) has expired and displays only a registrar's Expired Registration Recovery Policy notice, the operating status is flagged as "closed," and there is no record of products in market, customer relationships, pricing, distribution, or revenue. The structured contact information resolves to Key-Systems GmbH, a German domain registrar, rather than to the company itself. No patents, regulatory approvals, certifications, or post-2020 strategic activity are documented, indicating the company is either dormant, in turnaround, or no longer an active operating entity.

ODS Medical firmographics

Firmographics
Name
ODS Medical
Legal name
Key-Systems GmbH
Website
https://odsmed.com
Company type
Private
Founded year
2022
Operating status
Closed
Headcount range
11–50 employees
Short description
ODS Medical is a Montréal-based medical device company developing an exclusive Raman spectroscopy system for medical applications. Founded in 2015, the firm has historically targeted medtech commercialization but shows operational distress signals including an expired corporate domain and no documented commercial activity.
Ownership category
akta.pro rank

ODS Medical industry classification

Industry
Product category
Medical Diagnostic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Medical devices
  • Raman spectroscopy
  • Diagnostic imaging
  • Surgical guidance systems
  • Optical spectroscopy

Where ODS Medical is headquartered

Location

Headquarters

HQ city
Montreal
HQ country
Canada
HQ region
North America

Markets served

ODS Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations

ODS Medical product offering

Product offering

Core offering

ODS Medical is a medical device company developing and seeking to commercialize an exclusive Raman spectroscopy system. The system is positioned for diagnostic and intraoperative clinical applications, enabling optical tissue analysis for medical and surgical use cases. The company's primary commercial objective is to bring this proprietary Raman spectroscopy platform to healthcare markets.

Product overview

No product information available. The website (odsmed.com) displays only an expired domain registration notice with no product, service, or technology offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Raman Spectroscopy System An exclusive Raman spectroscopy-based medical device intended for clinical and intraoperative diagnostic applications, enabling optical tissue analysis for healthcare providers and surgical teams.

Companies that use ODS Medical

Customer profile

Ideal customer profiles1 record

ODS Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ODS Medical partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

ODS Medical competitors and assessment

Company assessment

Direct peers

  • Mauna Kea Technologies: Commercializes the Cellvizio probe-based optical biopsy platform for in-vivo tissue characterization during endoscopy and surgery. Directly comparable to ODS Medical as an optical/spectroscopy-based real-time tissue diagnostic medical device.
  • Verisante Technology: Canadian company developing Raman spectroscopy-based systems for skin cancer detection. Closely comparable in modality (Raman), clinical use case (cancer detection), and geography (Canada).
  • Perimeter Medical Imaging: Canadian AI-enabled OCT imaging company focused on real-time cancer margin assessment in the operating room. Comparable as a Canadian medtech commercializing optical tissue-analysis devices for surgical oncology.

Emerging players

  • MedLumics: Develops optical coherence tomography (OCT)-based cardiac imaging catheters. Comparable as a developer of optical diagnostic devices for clinical decision-making, though focused on cardiology rather than oncology/tissue spectroscopy.
  • Modulim: Uses spatial frequency domain imaging plus AI for tissue health assessment (e.g., diabetic foot, burns). Adjacent to ODS through the combination of optical physics and AI/ML for tissue characterization in clinical settings.
  • SpectralMD: Applies multi-spectral imaging and AI to wound care and burn assessment. Comparable through the use of optical spectroscopy/imaging with machine learning for clinical diagnostics.

Broad incumbents

  • Renishaw: Global manufacturer of Raman spectroscopy systems widely used in research and increasingly in medical/clinical research. Comparable as an established supplier of Raman spectroscopy instrumentation, though not exclusively medical-device focused.
  • HORIBA Scientific: Major manufacturer of Raman spectrometers and other analytical instruments with medical and life-science applications. Comparable as a broad incumbent in Raman spectroscopy hardware serving clinical and biomedical markets.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

ODS Medical social profiles

Digital presence

ODS Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ODS Medical leadership team

Management profile

Number of profiles

Profiles4 records

ODS Medical funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ODS Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ODS Medical

What does ODS Medical do?

ODS Medical is a medical device company developing and seeking to commercialize an exclusive Raman spectroscopy system. The system is positioned for diagnostic and intraoperative clinical applications, enabling optical tissue analysis for medical and surgical use cases. The company's primary commercial objective is to bring this proprietary Raman spectroscopy platform to healthcare markets.

Is ODS Medical a public or private company?

ODS Medical is a private company. It is classified as venture growth investor backed and is currently closed.

When was ODS Medical founded?

ODS Medical was founded in 2022. It employs 11 to 50 people.

Where is ODS Medical based?

ODS Medical is headquartered in Montreal, Canada, in the North America region.

Who are ODS Medical's main competitors?

Direct peers on record are Mauna Kea Technologies, Verisante Technology and Perimeter Medical Imaging. Emerging players are MedLumics, Modulim and SpectralMD. Broad incumbents are Renishaw and HORIBA Scientific.

Does ODS Medical have an API?

No public API is recorded for ODS Medical.

What industry is ODS Medical in?

ODS Medical's product category is Medical Diagnostic Devices. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals